Clinical Trials Directory

Trials / Completed

CompletedNCT00467766

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

A unique multinational study was conducted simultaneously in the USA, England and Australia. The goals of the study were to answer two questions: Does psychosocial support for the family enhance the effectiveness of drug treatment for Alzheimer's disease? Is the added value of psychosocial support the same in all 3 countries?

Detailed description

This study is a single-blind prospective randomized trial with 150 patient/caregiver pairs (50 in each country). Eligibility criteria at baseline require that the primary caregiver is the spouse of the patient; the patient must have a diagnosis of AD, be in the in mild to moderate stage of dementia, be living with the caregiver, and be willing to take Donepezil (Aricept). These participants were randomly assigned to one of two groups: in one group, the intervention consists of drug treatment for the patient plus psychosocial intervention for the caregiver; in the other group the intervention consists solely of drug treatment for the patient. The intervention for the caregiver consists of 5 scheduled individual and family counseling sessions within 3 months of baseline, and unlimited consultations on request. Assessments were conducted every 3 months for the first year and every 6 months for a second year. There are 3 sources of data: an interview of the caregiver by an independent rater, an assessment of the patient, and a count of the amount of medication used. Thus we will be able to assess the effect of adding counseling to medication for the caregiver, for the patient, and on compliance with medication use.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychosocial information, counseling, and support
DRUGDonepezil (Aricept)

Timeline

Start date
1999-07-01
Completion
2003-06-01
First posted
2007-05-01
Last updated
2007-05-07

Locations

3 sites across 3 countries: United States, Australia, United Kingdom

Source: ClinicalTrials.gov record NCT00467766. Inclusion in this directory is not an endorsement.